CD3D upregulation has been associated with resistance to anti-tumor therapy in patients with uveal melanoma, which was attributed to tumor infiltration by increased numbers of immune-suppressive regulatory T-cells [56]. The gene discussed is CD3D; the disease is uveal melanoma.